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Abstract
Introduction: A key aim of triage is to identify those with high risk of cardiac arrest, as they require intensive
monitoring, resuscitation facilities, and early intervention. We aim to validate a novel machine learning (ML) score
incorporating heart rate variability (HRV) for triage of critically ill patients presenting to the emergency department
by comparing the area under the curve, sensitivity and specificity with the modified early warning score (MEWS).
Methods: We conducted a prospective observational study of critically ill patients (Patient Acuity Category Scale 1
and 2) in an emergency department of a tertiary hospital. At presentation, HRV parameters generated from a 5-
minute electrocardiogram recording are incorporated with age and vital signs to generate the ML score for each
patient. The patients are then followed up for outcomes of cardiac arrest or death.
Results: From June 2006 to June 2008 we enrolled 925 patients. The area under the receiver operating
characteristic curve (AUROC) for ML scores in predicting cardiac arrest within 72 hours is 0.781, compared with
0.680 for MEWS (difference in AUROC: 0.101, 95% confidence interval: 0.006 to 0.197). As for in-hospital death, the
area under the curve for ML score is 0.741, compared with 0.693 for MEWS (difference in AUROC: 0.048, 95%
confidence interval: -0.023 to 0.119). A cutoff ML score ≥ 60 predicted cardiac arrest with a sensitivity of 84.1%,
specificity of 72.3% and negative predictive value of 98.8%. A cutoff MEWS ≥ 3 predicted cardiac arrest with a
sensitivity of 74.4%, specificity of 54.2% and negative predictive value of 97.8%.
Conclusion: We found ML scores to be more accurate than the MEWS in predicting cardiac arrest within 72 hours.
There is potential to develop bedside devices for risk stratification based on cardiac arrest prediction.
Introduction
In the emergency department (ED), triage is used to
assess the severity of patients’ conditions and to assign
appropriate treatment priorities. This clinical process
entails the rapid screening of large numbers of patients
to assess severity and assign treatment. Risk stratification
for cardiac arrest and other adverse cardiac outcomes
plays an essential role in the management of chest pain
patients in the ED [1]. Medical decisions for disposition
as well as the required level of intensive monitoring rest
on this perceived risk [2]. Risk stratification is a necessity
because medical resources are never sufficient for all
patients to be attended instantaneously in busy EDs and
hospitals, with limited numbers of doctors, nurses, moni-
tored beds, resuscitation facilities, intensive care beds,
operating theaters, and so forth. Quick identification of
patients of higher severity, who would more urgently
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need and potentially benefit from such resources, is thus
important.
Current risk-stratification systems are based on clinical
judgment and traditional vital signs including heart rate,
respiratory rate, blood pressure, temperature, and pulse
oximetry [3]. Unfortunately vital signs have not been
shown to correlate well with short-term or long-term
clinical outcomes [4]. The modified early warning score
(MEWS) is one such widely used tool (Table 1). The
MEWS is based on physiological parameters: systolic
blood pressure, pulse rate, respiratory rate, temperature
and AVPU score (A for ‘alert’, V for ‘reacting to vocal sti-
muli’, P for ‘reacting to pain’, U for ‘unconscious’). We
selected the MEWS as our comparator tool because it is
widely used in the UK and in Commonwealth countries
to identify patients at risk of deterioration, and raised
MEWS values are associated with increased mortality [5].
The MEWS can be relatively quickly calculated during
triage, without the need for laboratory test results, for
example. Other studies carried out in the UK have shown
good results in predicting poor outcomes in their patient
groups [5-7]. However, the assessment of the AVPU
score is a relatively subjective element in the scoring.
Also, the range of sensitivities and specificities are depen-
dent on the cutoff score used and the MEWS requires
some training to be accurate.
Heart rate variability (HRV) is a non-invasive measure-
ment for investigating autonomic influence on the cardio-
vascular system that has generated significant interest in
recent scientific literature [8]. HRV may be defined as the
change in the time interval between heartbeats, from beat
to beat. HRV is controlled by the autonomic nervous sys-
tem, including the sympathetic nervous system and the
parasympathetic nervous system [9,10]. There is recogni-
tion of a significant relationship between the autonomic
nervous system and cardiovascular mortality, including
sudden cardiac death [11,12]. Recent studies have found
strong associations between HRV from short-term (2 to
30 minutes) electrocardiogram (ECG) recordings and
post-acute myocardial infarction mortality [13,14]. These
associations suggest that short-term HRV measurements
may serve as a rapid risk-stratification tool for adverse car-
diac events.
Machine learning (ML) is based on the way the human
brain approaches pattern recognition tasks, providing an
artificial intelligence-based approach to solve classification
problems. A model is learned during the training process
using previously known input-output pairs. The trained
model is then tested with new data. Various ML topolo-
gies are available, including single-layer and multi-layer
feedforward networks. ML adjusts weights of hidden layers
during training to minimize an error function [15].
In this study, we aim to validate a novel ML score
incorporating HRV for risk stratification of critically ill
patients presenting to the ED by comparing the area
under the curve, sensitivity and specificity for prediction
of cardiac arrest with the MEWS.
Materials and methods
Study design
We conducted a prospective, nonrandomized, observa-
tional cohort study, looking at critically ill patients
attended by the Singapore General Hospital ED. Singa-
pore General Hospital is the oldest and largest acute ter-
tiary hospital in Singapore. The hospital accounts for
about one-third of all acute-care public-sector beds and
about one-quarter of acute beds nationwide. It is a Level
1 Trauma Centre for Singapore. Annually, about 60,000
patients are admitted to its wards and another 600,000
patients are attended to in its Specialist Outpatient
Clinics. The ED sees between 300 and 500 patients a day.
All public hospitals in Singapore use a national Patient
Acuity Category Scale (PACS) for triage at the ED. PAC
1 patients are the most critically ill and would therefore
be required to be attended to without delay. They
would most probably require maximum allocation of
staff and equipment resources for initial management.
The severity of their symptoms requires very early atten-
tion, failing which early deterioration of their medical
status is likely. PAC 2 patients are nonambulant and
would appear to be in a stable state on initial cardiovas-
cular examination and are not in danger of imminent
Table 1 Modified early warning score
Score Respiratory rate (breaths/minute) Heart rate (beats/minute) Systolic blood pressure (mmHg) Temperature (°C) AVPU
3 - - ≤ 70 - -
2 ≤ 8 ≤ 40 71 to 80 ≤ 35 -
1 - 41 to 50 81 to 100 35.1 to 36 -
0 9 to 14 51 to 100 101 to 199 36.1 to 38 Alert
1 15 to 20 101 to 110 - 38.1 to 38.5 Reacting to voice
2 21 to 29 111 to 129 ≥ 200 ≥ 38.6 Reacting to pain
3 > 29 > 129 - - Unresponsive
AVPU, A for ‘alert’, V for ‘reacting to vocal stimuli’, P for ‘reacting to pain’, U for ‘unconscious’.
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collapse. PACS 3 patients are ambulant and PACS 4
patients are nonemergencies. PACS is a symptom-based
triage system and does not have strict physiological cri-
teria (for example, vital sign cutoff values).
At Singapore General Hospital ED, all patients are
initially triaged by a nurse, and those with airway,
breathing and circulation problems, or those thought to
be possibly unstable and needing close monitoring, are
routinely put on ECG monitoring using the LIFEPAK®
12 defibrillator/monitor (Physio-Control, Redmond,
WA, USA). These would be PACS 1 patients and some
PACS 2 patients.
Patient recruitment and eligibility
All patients older than 18 years of age requiring contin-
uous ECG monitoring with PACS 1 or PACS 2 were eli-
gible. Patients in nonsinus rhythm (asystole,
supraventricular arrhythmias, ventricular arrhythmias,
complete heart block, and pacemaker rhythm) were
excluded because HRV metrics are not reliable for non-
sinus rhythms. Patients who were subsequently dis-
charged against medical advice or transferred to another
hospital for care were considered lost to follow-up and
excluded from the study as clinical outcomes could not
be determined. We also excluded cases with a high per-
centage of artifacts, nonsinus beats, and ectopics com-
bined together (> 30% of recorded tracing); cases with ≤
30% of artifacts and so forth were included, but the
nonsinus segments of the tracings were trimmed off.
Patients were only recruited during office hours. The
initial set of vital signs and HRV parameters obtained
during triage was recorded for this study. HRV record-
ings ranged from 5 to 30 minutes. Ethics approval was
obtained from the Singhealth Centralised Institutional
Review Board (CIRB Approval No. 2006/018/C) with a
waiver of patient consent for the study. Patients were
recruited from June 2006 to June 2008.
Hospital outcomes
The primary outcome was cardiac arrest within 72
hours of presentation to the ED. The event of cardiac
arrest was defined as sudden unexpected death or a
resuscitation event requiring cardiopulmonary assistance
(chest compressions and/or defibrillation). This assis-
tance was thought to probably reflect a primary cardiac
event/etiology. Information regarding the nature of
death or the resuscitation event was extracted from clin-
ical notes. The secondary outcome was death after
admission (in-hospital death during current admission,
including within 72 hours). This endpoint would have
included patients dying from primary cardiac as well as
noncardiac etiologies. Patients were followed up until
discharge or in-hospital death. Information regarding
the nature of death was extracted from clinical notes.
For patients who were discharged before 72 hours, elec-
tronic medical records providing information on admis-
sion to all public hospitals in Singapore were reviewed
for study outcomes.
Data collection and processing
ECG tracings (long lead I, II, III and 12-lead ECG data)
obtained during initial presentation from critically ill
patients on a LIFEPAK 12 defibrillator/monitor were
downloaded using the CODE-STAT Suite data review
software (version 5.0; Physio-control). Lead II ECGs
sampled at 125 Hz were extracted as text files for HRV
analysis using CODE-STAT™ and proprietary ECG
extraction software (Physio-Control); 125 Hz is the sam-
pling rate used by the defibrillator monitor. Since we
are primarily looking at the QRS complexes and not
interested in high-frequency features of the ECG, this is
a sufficient rate of digitization. Cases with ECG record-
ings were prospectively identified and had identity con-
firmed by querying ED charts and records. A minimum
ECG recording of 5 minutes is required in order to
accurately calculate HRV metrics.
The ECG records were converted into text (ASCII)
files using an extraction program available with CODE-
STAT. The processing program was embedded with a
MATLAB code (R2009a; The Mathworks, Natick, Mas-
sachusetts, USA), which was used to process the ECG
signals to obtain the HRV variables (see Figure 1), in
accordance with the guidelines outlined by the Task-
force of the European Society of Cardiology [16]. The
raw ECG data were first preprocessed to reduce the
effects of noise and artifacts using a 5 to 28 Hz band-
pass filter. This frequency range has been found to
enhance the QRS complex against the background noise
for easier peak detection [17]. A modified threshold-
plus-derivative method was used to detect the QRS
complexes, and all ectopics and other nonsinus beats
were excluded in accordance with the guidelines out-
lined by the Taskforce of the European Society of Cardi-
ology [16], using an automatic detection algorithm. RR
intervals were then calculated based on the sinus
rhythm. The beat detection and labeling techniques
have previously been validated against manually anno-
tated data from the MIT-BIH database [18] and have
been found to perform with high accuracy [19]. Ectopic
beats were identified by the size and shape of the QRS
complexes as well as the distances between successive
beats. The height of the QRS complex, width, and RR
interval were also considered. In addition, atrial fibrilla-
tion was identified manually by study engineers during
retrospective verification of ECGs.
The ECG tracings were then analyzed for heart rate
variability, with both time-domain and frequency-
domain analyses. Other variables collected were age,
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gender, medical history including ischemic heart disease,
diabetes mellitus and chronic renal failure, heart rate,
blood pressure, respiratory rate, Glasgow Coma Scale
(GCS), etiology, and medication history. Vital signs
(heart rate, blood pressure, and oxygen saturation
(SpO2)) were measured using the Propaq CS Monitor
(Welch Allyn, Skaneateles Falls, NY, USA) vital signs
monitor in the ED. The GCS and respiratory rate were
recorded at the time of vital sign measurement. AVPU
scores were recorded at triage. Tympanic temperatures
of the patients were taken using a tympanic thermo-
meter. AVPU scores were scored according to the best
response during data collection. The collected data were
used to calculate a MEWS for each patient recruited.
HRV variables measured included time-domain, fre-
quency-domain, and geometric parameters. The fre-
quency-domain parameters were calculated based on
estimates of power spectral density, obtained using the
Lomb-Scargle periodogram that is commonly used for
unevenly sampled sequences. Use of the Lomb-Scargle
periodogram eliminates the need for interpolation or
resampling of the sequences [20,21].
Machine learning score prediction
A ML-based prediction model - utilizing age, HRV para-
meters, and vital signs - was proposed to compute risk
score on patient’s hospital outcome [22]. This model was
run on a MATLAB code (R2009a; The Mathworks). In
contrast to traditional mathematical logistic regression
approaches, this is a multivariate, nonparametric, black-
box approach. This approach overcomes problems faced
by traditional statistical models of colinearity and overfit-
ting. Assuming that each patient’s data can be repre-
sented as a vector of HRV parameters and vital signs, the
scoring system is built based on the calculation of geo-
metric distances among a set of feature vectors (that is,
multiple patients). Classifier selection plays a key role in
building an efficient prediction system. In this study, the
support vector machine was adopted to map feature vec-
tors onto a higher dimensional space and find an optimal
pattern-separating hyperplane [23,24]. The support vec-
tor machine has shown satisfactory performances in
many areas including ECG beat classification [25], EEG
analysis [26], and text classification [27].
The calculation of the ML score is straightforward.
First, cluster centers of both positive and negative sam-
ples are calculated in Euclidean space, where positive
samples are patients with cardiac arrest or death as out-
comes and negative samples are patients without the
above outcomes. A score is then computed by evaluating
Euclidean distances between a patient’s data and both
cluster centers. Last, the risk score is fine-tuned through
a novel imbalanced learning strategy. If the predicted
outcome is positive, the risk score will be increased.
As shown in Table 2 the database consists of a majority
group of normal samples and a minority group of sam-
ples with abnormal outcomes (cardiac arrest or death);
that is, the dataset is imbalanced. Common ML algo-
rithms cannot be directly implemented on this imbal-
anced database for score tuning, because the majority
class will dominate the learning process and leads to
poor generalization performance on new patients from
Figure 1 List of heart rate variability parameters.
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the minority class. The solution to handling data imbal-
ance is to create a decision ensemble [28]. Our method
partitions the samples of majority class into N nonover-
lapped groups, with each group joined by minority sam-
ples. By doing so, N balanced datasets are created, on
which a prediction model is trained to distinguish minor-
ity and majority classes. The ML algorithm was trained
and validated using a leave-out-one strategy.
Statistical analyses
Continuous variables are presented as means (standard
deviation) or medians (interquartile range) and were
analyzed using a two-tailed Student’s t test and the
Wilcoxon rank-sum test, respectively. Categorical vari-
ables are presented as numbers (percentage) and were
analyzed using the chi-square test or Fischer’s exact test
when appropriate.
The ML score and the MEWS were calculated for all
patients and analyzed for a significant association
between the scores and the incidence of cardiac arrest
or death, and adverse cardiac events. Receiver operating
characteristic (ROC) curves were based on the continu-
ous measurements of the ML score and the ordinal
measurements of the MEWS.
Patients were categorized into low, intermediate, and
high risk groups according to their ML scores, based on
Table 2 Baseline characteristics of study patients
Characteristic No cardiac arrest within 72 hours (n = 882) Cardiac arrest within 72 hours (n = 43) P valuea
Age (years)
Median (IQR) 62 (50 to 74) 70 (59 to 78) 0.018
Male gender 542 (61.5) 31 (72.1) 0.198
Race
Chinese 586 (66.4) 35 (81.4)
Malay 130 (14.7) 5 (11.6) 0.134
Indian 118 (13.4) 1 (2.3)
Others 48 (5.4) 2 (4.7)
Diagnosis groupingb
Cardiovascular 359 (40.7) 9 (20.9)
Respiratory 137 (15.5) 10 (23.3)
Neurological 87 (9.9) 4 (9.3)
Gastrointestinal 46 (5.2) 0 (0)
Renal 25 (2.8) 0 (0)
Endocrine 58 (6.6) 4 (9.3) 0.275
Infectious diseases 59 (6.7) 1 (2.3)
Vascular 22 (2.5) 3 (7.0)
Trauma 31 (3.5) 2 (4.7)
Cancer 28 (3.2) 9 (20.9)
Others 30 (3.4) 1 (2.3)
Medical historyc
Diabetes 295 (33.4) 5 (11.6) 0.405
Hypertension 472 (53.5) 18 (41.9) 0.876
Heart disease 292 (33.1) 12 (27.9) 0.868
Renal disease 115 (13.0) 6 (14.0) 0.251
Respiratory disease 103 (11.7) 7 (16.3) 0.222
Stroke 63 (7.1) 0 (0) 1.000
Cancer 69 (7.8) 2 (4.7) 1.000
Others 523 (59.3) 32 (74.4) 0.204
Prior medical therapyd
Beta-blockers 227 (25.7) 14 (32.6) 0.726
Calcium-channel blockers 165 (18.7) 11 (25.6) 0.432
Digoxin 36 (4.1) 2 (4.7) 0.415
Amiodarone 12 (1.4) 0 (0) 1.000
Other anti-arrythmics 5 (1.4) 0 (0) 1.000
Data shown are numbers (%) unless otherwise stated. IQR, interquartile range (25th to 75th percentiles). aP value from either the chi-square test or the Mann-
Whitney test as appropriate. bBased on admitting emergency physician clinical diagnosis. cMedical history at presentation to the emergency department. dPrior
outpatient medical therapy at presentation to the emergency department.
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review of the data (selecting the cutoff values that pro-
vided the best discrimination): low risk, ML score 0 to
40; intermediate risk, ML score 41 to 60; and high risk,
ML score 61 to 100.
The area under the receiver operating characteristic
curve (AUROC) for the ML score and the MEWS was
calculated and compared using a z-statistic made from
the difference between the two AUROCs divided by the
standard error of the difference in the AUROCs [29].
The confidence interval (CI) for reporting the difference
between the two AUROCs was also derived. Statistical
comparison tests between the ML score and the MEWS
for sensitivity and specificity were done by applying the
McNemar test to the disease group (comparison of sen-
sitivities) and the nondiseased group (comparison of
specificities) [30]. Similarly, statistical comparison tests
between ML and the MEWS for the predictive values
were done using the above same method [30], whereby
the test statistics had a chi-square distribution with one
degree of freedom. A statistical comparison test for the
likelihood ratio of a positive test was not performed,
however, because no well-established method of com-
parison was found in the literature. Whenever possible,
the 95% CI for the difference in diagnostic value
between the two scoring methods was provided. For the
predictive values, the CI of the difference was not read-
ily computable by well-established methods, but signifi-
cance tests were carried out for these comparisons.
Moreover, separate CIs of the predictive value within
each scoring method are presented. A general rule of
thumb is that CIs can overlap as much as 29% and the
statistics can still be significantly different (see [31]
chapter 2.6: overlapping confidence intervals do not
imply nonsignificance). The ML score was further cate-
gorized into low, intermediate, and high risk scores and
was tested for a significant relationship with the rates of
cardiac arrest or death. Optimum cutoff points were
determined using sensitivity and specificity analysis.
Unless otherwise specified, P < 0.05 was considered to
indicate statistical significance. All data were stored with
Excel (Microsoft Office 2007; Microsoft, Redmond, WA,
USA) and imported into SPSS software (version 17.0;
SPSS Inc., Chicago, IL, USA) and STATA software (ver-
sion 11.1; STATA Corporation, College Station, TX,
USA) for statistical analysis.
Results
Baseline characteristics
A total of 1,025 ECG tracings were collected during this
period. Out of these tracings, 100 were excluded due to
a high percentage of artifacts, nonsinus beats, ectopics,
or missing data. A total of 925 patients were recruited
during the study. Table 2 shows the characteristics of
the study patients. The diagnosis grouping shown was
based on the admitting emergency physician clinical
diagnosis. The largest diagnosis grouping is the cardio-
vascular group at 468 (50.6%), followed by the respira-
tory group at 147 (15.9%).
Outcomes
Forty-three (4.6%) of the total sample developed cardiac
arrest within 72 hours, while 86 (9.3%) died after admis-
sion (including those deaths within 72 hours). The
respiratory diagnosis group had the largest number of
primary outcomes at 10 (23.3%), followed by cardiovas-
cular and cancer groups both at nine incidences (20.9%).
Both the gastrointestinal and renal groups did not have
any patients with primary outcome (cardiac arrest). The
respiratory diagnosis group has the largest number of
secondary outcomes at 19 (22.1%), followed by the car-
diovascular diagnosis group at 18 (20.9%).
Table 3 shows the relationship of the predictor factors
with the outcome of cardiac arrest within 72 hours and
death after admission. Those factors found to have sig-
nificant association (P < 0.05) with the primary outcome
included the GCS, pulse rate, respiratory rate, SpO2,
aRR, avHR, sdHR, RR triangular index, LS-VLF power,
LS-HF power, LS-LF norm, LS-HF norm, and MEWS.
Those factors found to have significant association (P <
0.05) with the secondary outcome included the GCS,
respiratory rate, SpO2, aRR, avHR, RMSDD, RR triangu-
lar index, TINN, LS-VLF power, LS-HF power, LS-LF
norm, LS-HF norm, LF/HF ratio, and MEWS.
The ROC and AUCs of the ML score and the MEWS
for predicting cardiac arrest within 72 hours or death
after admission are illustrated in Figure 2 and 3,
respectively.
Eighty-nine patients (9.6%), 576 patients (62.3%), and
260 patients (28.1%) were in the low, intermediate, and
high risk ML score groups, respectively. Rates of cardiac
arrest within 72 hours were 0%, 1.6% (95% CI: 6.59 to
9.79), and 13.1% (95% CI: 1.75 to 24.45) in the low,
intermediate, and high risk groups, respectively, as
shown in Figure 4. Rates of death after admission were
2.3% (95% CI: 18.48 to 23.08), 29.1% (95% CI: 11.30 to
46.90), and 68.6% (95% CI: 56.76 to 80.44) in the low,
intermediate, and high risk groups, respectively.
Table 4 shows the sensitivity, specificity, positive pre-
dictive values, and negative predictive values for the ML
score and the MEWS for predicting cardiac arrest
within 72 hours or death after admission. The AUROC
of the ML score was higher compared with the MEWS
for the primary outcome of cardiac arrest (0.781 vs.
0.680, difference in AUROC: 0.101, 95% CI: 0.006 to
0.197; P = 0.037) but not for the secondary outcome of
death. For prediction of cardiac arrest within 72 hours
after presentation, the sensitivity and specificity of the
ML score were 81.4 and 72.3, respectively, compared
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with sensitivity and specificity of the MEWS being 74.4
and 54.2, respectively (difference in sensitivity: 7.0, 95%
CI: -11.1 to 21.9; and difference in specificity: 18.1, 95%
CI: 14.3 to 22.0). Specificity for cardiac arrest but not
sensitivity was thus significantly higher in ML compared
with the MEWS. The positive predictive value of the
ML score was higher (12.5, 95% CI: 9.0 to 17.1) com-
pared with the positive predictive value of the MEWS
(7.4, 95% CI: 5.3 to 10.3; P < 0.001). The likelihood ratio
of a positive test for the ML score was higher (2.94, 95%
CI: 2.46 to 3.52) compared with the likelihood ratio of
the MEWS (1.62, 95% CI: 1.34 to 1.96). As for predic-
tion of death after admission, the specificity of the ML
score (73.9) was higher compared with the specificity of
the MEWS (55.7) (difference in specificity: 18.2; 95% CI:
14.3 to 22.2). The positive predictive value for the ML
score (21.5, 95% CI: 16.9 to 26.9) was higher compared
with the positive predictive value of the MEWS (14.7,
95% CI: 11.5 to 18.4; P < 0.001). The likelihood ratio of
the ML score (2.67, 95% CI: 2.23 to 3.20) was higher
compared with the likelihood ratio of the MEWS at
(1.68, 95% CI: 1.45 to 1.94).
Discussion
The results of this study showed that a ML score incor-
porating vital signs and HRV parameters is more predic-
tive of cardiac arrest within 72 hours of presentation to
the ED compared with the MEWS. Categorization of
patients into low, intermediate, and high risk groups
according to the ML score is a useful predictor of risk for
cardiac arrest and death. The ML score represents a non-
invasive and objective risk-stratification tool that can be
determined immediately at presentation to the ED. As
diagnosis in the ED setting is often time dependent, med-
ical decisions in the ED (disposition, level of monitoring,
aggressive management) are often made based on risk
assessment, rather than on diagnosis. We believe this is
the first study to show the potential of a ML model
Table 3 Measurements of MEWS, vital signs and heart rate variability of study patients






P valuea No death (n = 839) Death (n = 86) P valuea
Age 61 (16) 66 (16) 0.047 61 (16) 69 (16) < 0.001
Vital signs
Glasgow Coma Scale 15 (15 to 15) 15 (11 to 15) 0.002 15 (15 to 15) 15 (10 to 15) < 0.001
Temperature (°C) 37 (1) 37 (1) 0.118 37 (1) 37 (1) 0.280
Pulse rate (beats/minute) 96 (30) 106 (25) 0.026 96 (30) 102 (25) 0.055
Respiratory rate (breaths/minute) 19 (5) 20 (5) 0.040 19 (5) 20 (5) 0.021
Systolic BP (mmHg) 136 (38) 125 (34) 0.082 136 (37.899) 130 (40.761) 0.207
Diastolic BP (mmHg) 77 (22) 75 (20) 0.460 78 (21) 73 (23) 0.076
Oxygen saturation (%) 96 (6) 93 (13) < 0.001 96 (6) 94 (9) 0.001
Pain score 0 (0 to 3) 0 (0 to 3) 0.825 0 (0 to 3) 0 (0 to 0) 0.010
HRV variables
aRR (s) 0.718 (0.177) 0.621 (0.149) < 0.001 0.721 (0.175) 0.644 (0.176) < 0.001
STD (s) 0.053 (0.033) 0.057 (0.047) 0.490 0.054 (0.033) 0.051 (0.044) 0.534
avHR (beats/minute) 89.004 (20.566) 102.692 (22.136) < 0.001 88.582 (20.317) 99.971 (22.975) < 0.001
sdHR (beats/minute) 6.463 (3.740) 8.152 (5.531) 0.005 6.473 (3.731) 7.204 (4.877) 0.094
RMSSD (ms) 0.039 (0.041) 0.048 (0.054) 0.272 0.038 (0.039) 0.048 (0.063) 0.184
nn50 (count) 571 (1,268) 484 (748) 0.655 547 (1,178) 765 (1,800) 0.123
pnn50 7.048 (12.268) 6.561 (9.667) 0.797 6.878 (11.773) 8.460 (15.411) 0.251
RR triangular index 2.475 (1.000) 2.046 (0.736) 0.006 2.486 (1.000) 2.158 (0.840) 0.004
TINN (ms) 0.217 (0.130) 0.189 (0.148) 0.170 0.219 (0.130) 0.184(0.142) 0.017
VLF power (ms2) 0.131 (0.102) 0.099 (0.084) 0.045 0.133 (0.101) 0.098 (0.097) 0.002
LF power (ms2) 0.057 (0.042) 0.056 (0.045) 0.876 0.058 (0.043) 0.053 (0.040) 0.319
HF power (ms2) 0.080 (0.070) 0.103 (0.083) 0.032 0.079 (0.070) 0.100(0.077) 0.008
Total power (ms2) 0.268 (0.135) 0.259 (0.131) 0.673 0.269 (0.135) 0.251 (0.137) 0.223
LF power (nu) 45.430 (18.489) 36.459 (15.798) 0.002 45.938 (18.586) 35.990 (14.452) < 0.001
HF power (nu) 54.566 (18.487) 63.541 (15.798) 0.002 54.058 (18.583) 64.010 (14.452) < 0.001
LF/HF ratio 1.205 (1.284) 0.802 (1.171) 0.043 1.232 (1.299) 0.742 (0.992) 0.001
MEWS 2 (1 to 4) 4 (2 to 5) < 0.001 2 (1 to 4) 4 (2 to 5) < 0.001
Data shown are mean (standard deviation) or median (interquartile range, 25th to 75th percentiles). BP, blood pressure; HRV, heart rate variability; MEWS,
modified early warning score. aP value from either an unpaired t test or the Mann-Whitney test as appropriate.
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incorporating age, vital signs, and HRV for predicting
cardiac arrest and death.
Our study also indicates that HRV measured from
short-term ECG recordings (5 to 30 minutes), when
combined with vital signs, provides a useful tool for risk
stratification in the ED. In this study, depressed HRV
parameters were associated with early (72 hours) adverse
cardiac events and death after admission (Table 3). This
is consistent with the findings of previous studies that
suggest short-term measurement of frequency-domain
HRV parameters is strongly associated with cardiac
death and mortality [11-13,32].
Decreased HRV has been found to predict increased
mortality in the older patient [33], and for coronary
artery disease [14,34], post-myocardial infarction [11],
congestive heart failure [35], and dilated cardiomyopathy
[36]. Altered spectral HRV analysis has been found to be
an indicator of severity in congestive heart failure [37],
hypertension [38], coronary artery disease [39], angina
[40], myocardial infarction [41], hypovolemia, hypoxia
[42], chronic renal failure [43], and diabetes mellitus
[44]. Decreased HRV has also been found in ICU
patients following head trauma [45-49], sepsis [50], and
septic shock [51,52]. HRV has also been used as a mar-
ker of severity in ED patients with sepsis [53]. Depressed
HRV may reflect a decrease in vagal activity directed to
the heart that leads to prevalence of sympathetic
mechanisms [54], and therefore to cardiac instability,
which might explain the higher risk of arrhythmic
deaths [14,55]. However, the true sympatho-vagal corre-
lates of HRV and the mechanisms behind reduced HRV
still remain largely unknown [56].
In our previous research, we proposed using a combi-
nation of age, HRV measures, and vital signs as a pre-
dictor of patient outcomes and demonstrated that the
combined features present significant improvements to
predictive accuracy, sensitivity, and specificity compared
with using HRV alone [22,57]. As we can see from
Table 3 not all of the vital signs were highly predictive
when used in isolation. HRV parameters also tend to be
highly correlated. By using a ML approach, we were
able to overcome some of these limitations as well as
the overfitting associated with traditional statistical
methods [58]. We have investigated an extreme learning
machine and a support vector machine with different
activation/kernel functions as classifiers, and found that
the linear support vector machine is able to provide the
highest confidence in categorizing patients into two out-
comes: death and survival. Furthermore, we have also
presented a new segment-based decision-making strat-
egy for outcome prediction [22].
Limitations
Several limitations are inherent in our study. This study
was carried out in a single-center study at a tertiary
teaching hospital in Singapore and the results may not
be generalizable to other settings. However, we are con-
fident that the current dataset accurately represents the
management of ED patients in our hospital.
The diverse types of conditions in the patients
recruited may have different effects on the MEWS and
ML scores. The main diagnosis groupings are cardiovas-
cular, respiratory, neurological, gastrointestinal, renal,
Figure 2 Machine learning score and modified early warning
score predicting cardiac arrest within 72 hours. Receiver
operating characteristics (ROC) curve analysis of the machine
learning (ML) score and the modified early warning score (MEWS) in
predicting cardiac arrest within 72 hours.
Figure 3 Machine learning score and modified early warning
score predicting death within 72 hours. Receiver operating
characteristics (ROC) curve analysis of machine learning (ML) score
and the modified early warning score (MEWS) in predicting death
after admission.
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endocrine, infectious disease, vascular, trauma, cancer,
and others. The different diagnosis groupings may cause
inaccuracies in predicting the ML score because the
HRV in noncardiovascular conditions may differ from
that in cardiovascular-related conditions. In future
study, therefore, all of the different subgroups should be
analyzed separately.
Another limitation of our study is that while the ML
score has been shown to have good internal validity,
there is a need for external validation of the score for
routine clinical use.
One of the exclusion criteria of this study was the
exclusion of patients in nonsinus rhythm. It remains to
be seen whether the ML score will remain a good pre-
dictor of adverse outcomes in patients with irregular
heart rhythms. Previous studies in patients with atrial
fibrillation have found an association between HRV and
an increased risk for cardiac death [59], as well as recur-
rence of atrial fibrillation [60]. Patients in atrial fibrilla-
tion, however, only represent a minority of patients,
estimated to be approximately 2 to 4% in patients
between ages 60 and 79 [61] and < 1% in patients below
the age of 55 [61]. Another limitation of our study is
the lack of follow-up for patients discharged from the
ED. Electronic medical records of patients that were dis-
charged before 72 hours were also checked for any
Figure 4 Rates of cardiac arrest within 72 hours and death in relation to machine learning score. *, **.
Table 4 Discriminatory values of the machine learning score and the modified early warning score
Variable ML score (95% CI)a MEWS (95% CI)b Difference (95% CI for difference)c P value
Cardiac arrest within 72 hours after presentation
Area under ROC curve 0.781 0.680 0.101 (0.006 to 0.197) 0.037
Sensitivity 81.4 74.4 7.0 (-11.1 to 21.9) 0.581
Specificity 72.3 54.2 18.1 (14.3 to 22.0) < 0.001
Positive predictive value 12.5 (9.0 to 17.1) 7.4 (5.3 to 10.3) < 0.001
Negative predicting value 98.8 (97.5 to 99.4) 97.8 (95.9 to 98.8) 0.133
Likelihood ratio (+)d 2.94 (2.46 to 3.52) 1.62 (1.34 to 1.96)
Death after admissione
Area under ROC curve 0.741 0.693 0.048 (-0.023 to 0.119) 0.185
Sensitivity 69.8 74.4 -4.7 (-16.7 to 7.4) 0.572
Specificity 73.9 55.7 18.2 (14.3 to 22.2) < 0.001
Positive predictive value 21.5 (16.9 to 26.9) 14.7 (11.5 to 18.4) < 0.001
Negative predicting value 96.0 (94.1 to 97.3) 95.5 (93.2 to 97.1) 0.608
Likelihood ratio (+)d 2.67 (2.23 to 3.20) 1.68 (1.45 to 1.94)
CI, confidence interval; MEWS, modified early warning score; ML, machine learning; ROC, receiver operating characteristic. aA cutoff value of 60 and above was
used for the ML score. bA cutoff value of 3 and above was used for the MEWS. cThe 95% confidence interval for the difference between the ML score and the
MEWS for each diagnostic statistic was calculated, except for positive predictive value, negative predictive value, and likelihood ratio (+) that are not well
established. dLikelihood ratio of a positive test. eIn-hospital death during current admission. 95% confidence interval or statistical test not computed because the
method is not well established for the diagnostic statistics concerned.
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admissions to public hospitals in Singapore to minimize
missed cases of adverse cardiac events.
The ML score is also based on a single ECG record-
ing. Although this represents a rapid method for risk
stratification, not much is known about the change of
HRV variables over time. Studies have suggested that
acute changes in HRV occur before the onset of ventri-
cular tachycardia [62-65]. Changes over time in HRV
have also been found to occur in the early phase of
recovery after myocardial infarction [66-68]. Serial ana-
lyses of changes in HRV were not performed in our
study and should be investigated for in follow-up
studies.
Future studies
The results of this study should be validated with a lar-
ger sample size, in view of the rare outcome of cardiac
arrest within 72 hours or death. Further studies should
also be carried out to validate the ML score in a pro-
spective series in patients with different diagnosis
groupings.
We have since developed a laptop-based prototype to
acquire real-time signals and to process and analyze
HRV parameters. This device incorporates ECG and
other vital signs such as blood pressure, pulse oximetry,
and respiratory rate, together with clinical data, for
instantaneous, intelligent prediction of cardiac arrest
and mortality using neural networks. In the future, we
aim to prospectively validate the prediction scores gen-
erated by our device with critically ill patients, including
the assessment of the effect of ongoing treatment on
our prediction index and survival. Further development
is also needed to produce a stand-alone device, ready
for clinical use and possible clinical trials. We believe
that there exists potential for the development of bed-
side devices capable of real-time monitoring of HRV,
which may help physicians to identify patients at high
risk for cardiac arrest and death.
Conclusion
In critically ill patients presenting to the ED, we found
ML scores to be more accurate than the MEWS in pre-
dicting cardiac arrest within 72 hours. The results of
this study also suggest that initial short-term HRV mea-
surements, in addition to vital signs, may play a role for
early, rapid, and objective risk stratification of patients
during triage.
Key messages
• We determined the relationship of the predictor
factors with the outcome of cardiac arrest within 72
hours and death after admission. Significant associa-
tion (P < 0.05) with the primary outcome included
the GCS, pulse rate, respiratory rate, SpO2, aRR,
avHR, sdHR, RR triangular index, LS-VLF power,
LS-HF power, LS-LF norm, LS-HF norm, and
MEWS.
• Those factors found to have significant association (P
< 0.05) with the secondary outcome included the GCS,
respiratory rate, SpO2, aRR, avHR, RMSDD, RR trian-
gular index, TINN, LS-VLF power, LS-HF power, LS-
LF norm, LS-HF norm, LF/HF ratio, and MEWS.
• The AUROCs of the ML score for both primary
and secondary outcomes (0.781 and 0.741, respec-
tively) are higher compared with those for the
MEWS (0.680 and 0.693, respectively).
• The sensitivity and specificity of the ML score are
81.4 (95% CI: 66.1 to 91.1) and 72.3 (95% CI: 69.2 to
75.2), respectively; both are higher compared with the
sensitivity and specificity of MEWS (74.4, 95% CI: 58.5
to 86.0; and 54.2, 95% CI: 50.8 to 57.5, respectively).
• In critically ill patients presenting to the ED, we
found ML scores to be more accurate than the
MEWS in predicting cardiac arrest within 72 hours
and death.
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